We are live on
!
Find out more
SC
Sepio Capital Portfolio holdings
AUM
$1.99B
1-Year Est. Return
22.34%
This Fund
S&P 500
This Quarter
Est. Return
+0.52%
1 Year Est. Return
+22.34%
3 Year Est. Return
+75.23%
5 Year Est. Return
+90.09%
10 Year Est. Return
–
AUM
$1.09B
AUM Growth
-$75M
(-6.4%)
Cap. Flow
-$70.5M
Cap. Flow
% of AUM
-6.46%
Top 10 Holdings %
Top 10 Hldgs %
42.38%
Holding
290
New
6
Increased
62
Reduced
168
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pacer Developed Markets International Cash Cows 100 ETF
ICOW
|
+$6.83M |
| 2 |
IMVP
Invesco India ETF
IMVP
|
+$3.08M |
| 3 |
VictoryShares Free Cash Flow ETF
VFLO
|
+$2.9M |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$2.57M |
| 5 |
iShares MSCI Turkey ETF
TUR
|
+$2.51M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bushido Capital US Equity ETF
SMRI
|
+$29.2M |
| 2 |
NVIDIA
NVDA
|
+$6.26M |
| 3 |
iShares S&P 500 Value ETF
IVE
|
+$5.03M |
| 4 |
AbbVie
ABBV
|
+$4.64M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.63M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.63% |
| 2 | Healthcare | 7.29% |
| 3 | Financials | 5.48% |
| 4 | Communication Services | 5.21% |
| 5 | Consumer Discretionary | 5.05% |
Similar funds
SC
CAM
RMCM
CCA
RCM
LGM
MYAM
LBC
Sepio Capital's Q2 2024 Portfolio in Review
As of Q2 2024, Sepio Capital held 290 positions worth $1.09B, down 6.4% from $1.17B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Sepio Capital withdrew a net $70.5M in Q2 2024, closing 14 positions and reducing 168 holdings. Its most notable exit was Merrimack Pharmaceuticals, Inc., an estimated $4.41M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Sepio Capital opened a new position in Invesco India ETF worth $3.26M.
- Sepio Capital's largest Q2 2024 buy was Invesco India ETF: 111,394 shares worth $3.26M.
- Sepio Capital added most to Pacer Developed Markets International Cash Cows 100 ETF in Q2 2024, an estimated $6.83M increase.
- Sepio Capital's biggest Q2 2024 reduction was Bushido Capital US Equity ETF, cutting an estimated $29.2M.
- Sepio Capital fully exited Merrimack Pharmaceuticals, Inc. in Q2 2024, selling an estimated $4.41M.
- Sepio Capital's ten largest holdings make up 42% of its $1.09B portfolio in Q2 2024.
- Sepio Capital opened 6 new positions and closed 14 in Q2 2024.
- Sepio Capital's portfolio value fell 6.4% quarter-over-quarter to $1.09B.
Based on Sepio Capital's 13F filing for Q2 2024, filed 15 Aug 2024.